Chinese Vitamin C Makers Win Dismissal of $147 Million Judgment

  • North China Pharmaceutical and Hebei Welcome win U.S. ruling
  • Companies can’t be held liable for price fixing, court says

Two Chinese drug companies won dismissal of a $147 million antitrust verdict after a federal appeals court ruled they were acting under Chinese law and couldn’t be held liable in the U.S. for fixing prices.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.